Factual Background. On December 30, 2008, the Company entered into a Preferred Stock Purchase Agreement with ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ and X-Master, Inc., (the "Investors") pursuant to which the Investors agreed to purchase at least ten (10) shares of Series D Preferred Stock from the Company for a purchase price of up to Five Million Dollars ($5,000,000 USD). As a material and essential inducement for the Investors to enter into the Preferred Stock Purchase Agreement, the Company agreed to employ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ and ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ in accordance with the terms thereof.
Appears in 2 contracts
Sources: Series D Preferred Stock Purchase Agreement (International Stem Cell CORP), Employment Agreement (International Stem Cell CORP)
Factual Background. On December 30, 2008, the Company entered into a Preferred Stock Purchase Agreement with ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇, and X-Master, Inc., (the "Investors") pursuant to which the Investors agreed to purchase at least ten (10) shares of Series D Preferred Stock from the Company for a purchase price of up to Five One Million Dollars ($5,000,000 1,000,000 USD). As a material and essential inducement for the Investors to enter into the Preferred Stock Purchase Agreement, the Company agreed to employ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ and ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ in accordance with the terms thereof.
Appears in 2 contracts
Sources: Series D Preferred Stock Purchase Agreement (International Stem Cell CORP), Employment Agreement (International Stem Cell CORP)